0J
iShares Biotechnology ETF (0JGB)
LSE
214.09
+2.78 (+1.31%)
Real-time Data
07:00 AM
Day's Range
211.47215.13
52 wk Range
137.20215.16
Financial Statements - 0JGB - iShares Biotechnology ETF
Revenue
4.74B▲ 32.6%
Net Income
403.21M▲ 6.5%Net Margin 8.5%
EBITDA
921.03M▲ 29.6%
Free Cash Flow
-276.60M▼ 244.4%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 4.74B | 3.57B | 3.45B | 3.69B |
| Cost of Goods | 3.67B | 2.61B | 2.54B | 2.79B |
| Gross Profit | 1.07B | 967.95M | 907.92M | 896.58M |
 Operating Expense | - | - | - | - |
| Operating Income | 487.85M | 461.47M | 486.97M | 454.13M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 486.10M | 389.38M | 547.06M | 665.36M |
| Income Tax | 82.88M | 64.28M | 109.20M | 145.18M |
| Net Income | 403.21M | 378.56M | 437.85M | 520.18M |
| EPS Basic | 0.1121 | 0.0962 | 0.1097 | 0.131 |
| EPS Diluted | 0.1121 | 0.0962 | 0.1097 | 0.131 |
| Basic Shares Outstanding | 3.08B | 3.08B | 3.08B | 3.08B |
| Diluted Shares Outstanding | 3.08B | 3.08B | 3.08B | 3.08B |
| Ebit | - | - | - | - |
| Ebitda | 921.03M | 710.88M | 812.17M | 886.36M |
| Net Income Continuous Operations | 486.10M | 442.84M | 547.06M | 665.36M |
| Minority Interests | -57.45M | -81.88M | -99.50M | -116.06M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
